Detection of intestinal pathogens through host surveillance of bacterial toxins
通过宿主细菌毒素监测来检测肠道病原体
基本信息
- 批准号:10540312
- 负责人:
- 金额:$ 3.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Anti-Infective AgentsAnti-Inflammatory AgentsBacteriaBacterial ToxinsBone Marrow TransplantationCaenorhabditis elegansCell CommunicationCellsCessation of lifeCommunitiesDataDetectionDevelopmentEmbryonic DevelopmentEpithelial CellsFamilyGenesGenetic TranscriptionHNF4A geneHealthHomologous GeneHormone ReceptorHospitalizationHumanImmuneImmune responseImmunocompromised HostInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInnate Immune ResponseIntestinesLigandsMetabolismModelingMolecularMonitorNatural ImmunityNuclear Hormone ReceptorsNuclear ReceptorsOrganismOxidation-ReductionPathogen detectionPathogenesisPathogenicityPatientsPattern RecognitionPattern recognition receptorPhenazinesPhysiologicalPositioning AttributeProcessProtein IsoformsPseudomonas aeruginosaPseudomonas aeruginosa infectionResearchRoleSepsisSepticemiaTestingTherapeuticToxinTranscriptional ActivationTransplant RecipientsVirulencechemotherapycommensal bacteriacommensal microbesenteric infectionenteric pathogengut colonizationgut inflammationgut microbiomehuman pathogenimmune activationimmunoregulationinsightinterestintestinal epitheliummodel organismmutantnovelpathogenpathogenic bacteriapathogenic microbeprogramsresponsetherapeutic targettranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
Although commensal and pathogenic bacteria can be recognized by host pattern recognition receptors,
intestinal epithelial cells target protective inflammatory responses towards pathogenic organisms through
mechanisms that are incompletely understood. Additional mechanisms of pathogen sensing must exist that
allow intestinal cells to target inflammatory defenses towards bona fide pathogens during an infection, and not
harmless commensal bacteria. Pathogenic bacteria can express virulence determinants. Phenazine toxins are
a family of redox active virulence determinants that are produced by a variety of human pathogens, including P.
aeruginosa. P. aeruginosa can colonize the intestines of immunocompromised patients and cause fulminant
septicemia and subsequent death. The mechanism by which intestinal epithelial cells detect P. aeruginosa, and
whether this involves the surveillance of phenazine toxins, is not known. Nuclear hormone receptors (NHR) are
transcription factors that program adaptive host responses following recognition of specific exogenous or
endogenous ligands. In particular, HNF4⍺ is an NHR expressed in the intestine. In the model organism C.
elegans, the HNF4⍺ homolog NHR-86 is required for the transcriptional activation of innate immune effector
genes that protect against P. aeruginosa infection. The central hypothesis of this proposal is that intestinal
epithelial cells detect infection through the surveillance of pathogen-derived phenazine toxins by NHR-86/
HNF4⍺, which directly activates protective anti-pathogen defenses in the intestinal epithelium. The following
key preliminary findings support this central hypothesis: i) P. aeruginosa mutants that cannot make phenazine
toxins do not activate C. elegans innate immune defenses; ii) synthetic phenazine toxins can activate immune
genes; and iii) induction of immune genes by phenazine toxins is dependent on the expression of NHR-86/
HNF4⍺. In this proposal, Aim 1 will characterize the C. elegans immune response towards bacterial phenazine
toxins, and Aim 2 will define the role of intestinal NHR-86/HNF4⍺ in detecting P. aeruginosa infection in C.
elegans. The research proposed here will define a new concept of immune activation in intestinal epithelial
cells and will also attribute a novel role for NHRs in pathogen sensing in the intestine. Insights from these
findings may identify unexplored approaches for the development of anti-inflammatory and anti-infective
therapies.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samantha Tse其他文献
Samantha Tse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samantha Tse', 18)}}的其他基金
Detection of intestinal pathogens through host surveillance of bacterial toxins
通过宿主细菌毒素监测来检测肠道病原体
- 批准号:
10321888 - 财政年份:2021
- 资助金额:
$ 3.27万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 3.27万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 3.27万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 3.27万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 3.27万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 3.27万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 3.27万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 3.27万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 3.27万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 3.27万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 3.27万 - 项目类别: